Compare IOVA & APLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IOVA | APLD |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.5B |
| IPO Year | 2008 | 2021 |
| Metric | IOVA | APLD |
|---|---|---|
| Price | $8.34 | $17.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 16 |
| Target Price | $14.40 | ★ $62.44 |
| AVG Volume (30 Days) | 12.3M | ★ 23.0M |
| Earning Date | 11-05-2026 | 10-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.84 | ★ 21.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $611,311,000.00 |
| Revenue This Year | $56.63 | $59.91 |
| Revenue Next Year | $43.83 | $101.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 167.45 |
| 52 Week Low | $1.76 | $17.50 |
| 52 Week High | $15.37 | $50.73 |
| Indicator | IOVA | APLD |
|---|---|---|
| Relative Strength Index (RSI) | 29.97 | 35.18 |
| Support Level | $7.85 | N/A |
| Resistance Level | $9.36 | $29.08 |
| Average True Range (ATR) | 0.98 | 1.52 |
| MACD | -0.75 | -0.02 |
| Stochastic Oscillator | 1.76 | 4.97 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
Applied Digital Corp is a U.S. based designer, developer, owner, and operator of large-scale, purpose-built data centers engineered to support high-performance computing (HPC) workloads, including artificial intelligence (AI), machine learning, and other accelerated-compute applications. It design, build, and operate high-performance, sustainably engineered data centers which it refer to as AI factories and deliver that capacity to investment-grade hyper scalers and other compute customers under long-term lease and hosting arrangements. The company has two segments Data Center Hosting Business, and HPC Hosting Business. The company generates majority of revenue from Data Center Hosting Business segment. Its solutions are Digital Infrastructure, and AI Factories.